Rapid Nitric Oxide Production Research Articles

Hyperglycemia Induces Remodeling of Nitric Oxide Synthase Activity in Glomerular Podocytes

Background: The regulation of glomerular filtration is influenced by the renin-angiotensin system (RAS) and the release of nitric oxide (NO) by glomerular cells. Several studies suggest that NO levels in glomeruli decrease as renal pathology develops, and restoring NO levels can be beneficial for glomerular function. Despite these findings, the expression of nitric oxide synthase (NOS) subunits in podocytes, particularly under pathological conditions, still requires further investigation. We hypothesized that decreased NO bioavailability in diabetes and hyperglycemia is linked to pathological NOS remodeling, thus influencing redox balance in podocytes and promoting renal damage. Methods: Live-cell confocal imaging was used to investigate NO production and the distribution of NOS in both control and hyperglycemic conditions. First, we used immortalized human podocytes (obtained from M. Saleem lab) loaded with the DAF-FM fluorescent marker in control and hyperglycemic (exposed to high glucose for 12 hours) conditions. Next, freshly isolated glomeruli from Type 2 Diabetic Nephropathy (T2DN) and Wistar male rats (age 26-30 weeks) were used to confirm our data ex vivo. NO production was monitored following Angiotensin II (Ang II) stimulation, and the distribution of NOS was determined using specific NOS1 and NOS2 commercially available inhibitors (Nω-Propyl-L-arginine hydrochloride and L-NIL, respectively). One-way ANOVA (OriginPro) was used for statistical analysis. Results: Upon application of Ang II, rapid NO production was observed in cultured and Wistar rats isolated glomeruli podocytes. The release of NO was blocked by preincubation with corresponding inhibitors targeting NOS. Our findings reveal that NOS1 primarily contributes to signaling in healthy podocytes, accounting for 69±5% of the total NO response, while the remaining NO production mediated by the RAS is attributed to NOS2 (39±5%). In diabetic conditions, the maximal amplitude of NO production mediated by Ang II was decreased by 22±10% compared to the control (one-way ANOVA, n≥24, p<0.001). Furthermore, high glucose conditions significantly altered NOS distribution in podocytes, where NOS2 signaling became predominant (89±7% of the total NO response), and the contribution of NOS1 became less significant. Conclusions: The changes in the distribution of NO sources could be associated with heightened oxidative and nitrosative stress, promoting renal damage. Our research demonstrates that in diabetes, NOS2 activity becomes predominant, potentially playing a direct role in advancing pathological processes in podocytes. Revealing the mechanisms of this fundamental pathway in the glomerulus impacts our progress toward new treatment and preventive measures for diabetic kidney disease development. This research was supported by National Institutes of Health Grants R01 DK126720 (to OP), R01 DK129227 (to AS and OP), and R01 DK115749 (to KS), US Department of Veteran Affairs grants I01CX002391 (to JHL), I01CX001248 (JCO) and I01 BX004024 (to AS). This is the full abstract presented at the American Physiology Summit 2024 meeting and is only available in HTML format. There are no additional versions or additional content available for this abstract. Physiology was not involved in the peer review process.

A Role for iNOS in Erastin Mediated Reduction of P-Glycoprotein Transport Activity.

The blood-brain barrier is composed of both a physical barrier and an enzymatic barrier. Tight junction (TJ) proteins expressed between endothelial cells of brain capillaries provide the physical barrier to paracellular movement of ions and molecules to the brain, while luminal-facing efflux transporters enzymatically restrict the entry of blood-borne molecules from entering the brain. The expression and activity of ATP Binding Cassette transporters or "ABC" transporters in endothelial cells of the BBB and in human tumor cells are dynamically regulated by numerous signaling pathways. P-glycoprotein (P-gp), (ABCB1), is arguably the most studied transporter of the BBB, and in human cell lines. P-glycoprotein transport activity is rapidly inhibited by signaling pathways that call for the rapid production of nitric oxide (NO) from the inducible nitric oxide synthase enzyme, iNOS. This study investigated how nano-molar levels of the selective chemotherapeutic erastin affect the activity or expression of P-glycoprotein transporter in brain capillaries and in human tumor cell lines. We chose erastin because it signals to iNOS for NO production at low concentrations. Furthermore, erastin inhibits the cellular uptake of cystine through the XC- cystine/glutamate antiporter. Since previous reports indicate that NO production from iNOS can rapidly inhibit P-gp activity in tumor cells, we wondered if induction of iNOS by erastin could also rapidly reduce P-glycoprotein transport activity in brain endothelial cells and in human tumor cell lines. We show here that low concentrations of erastin (1 nM) can induce iNOS, inhibit the activity of P-glycoprotein, and reduce the intracellular uptake of cystine via the Xc- cystine/glutamate antiporter. Consistent with reduced P-glycoprotein activity in rat brain capillary endothelial cells, we show that human tumor cell lines exposed to erastin become more sensitive to cytotoxic substrates of P-glycoprotein.

Abstract LB267: Nitric oxide suppression by secreted frizzled-related protein 2 drives retinoblastoma

Abstract Retinoblastoma is a cancer of the infant retina primarily driven by the loss of the Rb tumor suppressor gene, which is undruggable. Here, we identified an autocrine signaling, mediated by secreted frizzled-related protein 2 (SFRP2), which suppresses nitric oxide and enables retinoblastoma growth. SFRP2 silencing resulted in rapid production of nitric oxide, leading to p53-dependent growth arrest of retinoblastoma cells. We show that coxsackievirus and adenovirus receptor (CXADR) is the cell surface receptor for SFRP2 in retinoblastoma cells, that CXADR functions as a "dependence receptor," transmitting a growth inhibitory signal in the absence of SFRP2, and that the balance between SFRP2 and CXADR determines nitric oxide production. Accordingly, high SFRP2 RNA expression correlates with high-risk histopathologic features in retinoblastoma. Targeting SFRP2 signaling by SFRP2-binding peptides or by a pharmacological inhibitor rapidly induced nitric oxide and profoundly inhibited retinoblastoma growth in orthotopic xenograft models. These results reveal a cytokine signaling pathway that regulates nitric oxide production and retinoblastoma cell proliferation, and is amenable to therapeutic intervention. Citation Format: Panneerselvam Jayabal, Xiuye Ma, Kathryn M. Bondra, Yidong Chen, Peter J. Houghton, Yuzuru Shiio. Nitric oxide suppression by secreted frizzled-related protein 2 drives retinoblastoma [abstract]. In: Proceedings of the American Association for Cancer Research Annual Meeting 2023; Part 2 (Clinical Trials and Late-Breaking Research); 2023 Apr 14-19; Orlando, FL. Philadelphia (PA): AACR; Cancer Res 2023;83(8_Suppl):Abstract nr LB267.

Biophysical Properties of Endothelial Mechanotransduction Mediated by Glycocalyx

Endothelial surface glycocalyx (ESG) is a carbohydrate‐rich layer found on the endothelial cell (EC) surface lining all blood vessels' inner lumen. Composed of membrane glycoproteins, glycosaminoglycans (GAGs), such as hyaluronan and heparan sulfate (HS), and proteoglycans, the ESG forms a bulky, gel‐like layer serving critical functions in blood flow mechanotransduction, endothelial permeability maintenance, leukocyte adhesion, and inflammation control. ESG is known for sensing shear stress of blood flow and transducing the mechanical signal into nitric oxide (NO) production. NO is an essential signaling molecule to regulate vascular tone. To date, the molecular pathways of ESG‐mediated mechanotransduction have not been completely clear.We utilize a custom‐built AFM with fluorescence imaging capabilities to vertically stretch the ESG, which applies a pulling force to specific ESG components on the surface of a single live mouse brain endothelial cell (bEnd.3) and quantify the cell's NO production in real‐time. NO production is quantified by the fluorescent dye DAF‐FM. AFM probe is coated with monoclonal antibodies against HS or glypican‐1 (a major core protein for HS) to exert pulling forces onto the HS or glypican‐1 on bEnd.3. To ensure that DAF intensity is a signal of NO production, we treated the cells with L‐NAME (an inhibitor of endothelial nitric oxide synthase). The DAF intensity was greatly reduced, which confirms that the DAF intensity is representing NO production.The AFM anti‐glypican‐1 coated probe showed an increase in DAF intensity, while the anti‐HS probe is shown to have a slight rise in DAF intensity. Since HS may attach to other proteins besides glypican, the data suggest that glypican‐1 is a more critical mechanotransducer. Our prior study indicated cation‐permeable, transient receptor potential (TRP) ion channels mediate stretch‐induced NO production. Probes were coated in glypican‐1 while the cells were exposed to Amiloride or SKF96365, blockers of TRPP2 and TRPC1 channels, respectively. After the Amiloride‐treated cells were mechanically stimulated, there was a reduction of NO production. However, the amount of NO output was still significant over the basal levels observed in cells. When the SKF96365‐treated cells were mechanically stimulated, production was inhibited entirely, thus, demonstrating TRPC1 channels play a vital role in allowing the Ca2+ into the cell to begin NO production cascade.These findings confirm the critical roles of HS, glypican‐1, and TRP channels on the rapid NO production resulting from mechanical signaling and have important implications for ESG‐related cardiovascular diseases such as diabetes, strokes, cardiac arrest, and atherosclerosis. It has been shown that intracellular Ca2+regulates eNOS activity. In future studies, we will measure the Ca2+intake mediated by TRP channels and delineate the interplay among mechanical stretch, TRP channel activation, Ca2+intake and NO production.

Mechanotransduction of the endothelial glycocalyx mediates nitric oxide production through activation of TRP channels.

The endothelial surface glycocalyx (ESG) is a carbohydrate-rich layer found on the vascular endothelium, serving critical functions in the mechanotransduction of blood flow-induced forces. One of the most important protective functions of the ESG is to mediate the production of nitric oxide (NO) in response to blood flow. However, the detailed mechanism underlying ESG's mechanotransduction of the production of NO has not been completely identified. Herein, using the cultured rat brain microvascular endothelial cells (bEnd.3) as a model system, we have implemented a combined atomic force and fluorescence microscopy approach to show that the ESG senses and transduces vertical mechanical stretch to produce NO. This rapid NO production is dependent on the presence of both heparan sulfate (HS) and hyaluronic acid (HA) in ESG, as the removal of HS and/or HA leads to a significant decrease in NO production. Moreover, the production of NO is dependent on the intake of Ca2+ via endothelial transient receptor potential (TRP) channels. Together, our results demonstrate the molecular mechanism of rapid production of NO in response to vertical mechanical stretch.

The Therapeutic Potential of Toll-Like Receptor 7 Stimulation in Asthma

Asthma is an inflammatory disorder of the airways frequently characterized by an excessive Th2 adaptive immune response. Activation of Toll-like receptor (TLR)-7, a single-stranded viral RNA receptor that is highly expressed in the airways, triggers a rapid innate immune response and favors a subsequent Th1 response. Because of this role in pulmonary immunoregulation, TLR7 has gained considerable interest as a therapeutic target in asthma. Synthetic TLR7 ligands, including the imidazoquinolines imiquimod (R837) and resiquimod (R848), and 8-hydroxyadenine derivatives have been developed for other clinical indications. TLR7 activation prevents ovalbumin-induced airway hyperreactivity, eosinophilic inflammation, goblet cell hyperplasia and airway remodeling in murine models of asthma. TLR7 activation also inhibits viral replication in the lung and prevents virus-induced airway hyperreactivity. Furthermore, it has recently been shown that stimulating TLR7 rapidly relaxes airway smooth muscle, dilating the airways. This bronchodilating effect, which occurs in seconds to minutes and depends on rapid production of nitric oxide, indicates that TLR7 can signal via previously unrecognized pathways. The effects of decreasing the allergic Th2 response, acting as an immediate bronchodilator, and promoting an antiviral immune environment, make TLR7 an attractive drug target. We examine the current understanding of TLR7 as a therapeutic target and its translation to asthma treatment in humans.

Sustained Generation of Nitric Oxide and Control of Mycobacterial Infection Requires Argininosuccinate Synthase 1

Nitric oxide (NO) defends against intracellular pathogens, but its synthesis must be regulated due to cell and tissue toxicity. During infection, macrophages import extracellular arginine to synthesize NO, generating the byproduct citrulline. Accumulated intracellular citrulline is thought to fuel arginine synthesis catalyzed by argininosuccinate synthase (Ass1) and argininosuccinate lyase (Asl), which would lead to abundant NO production. Instead, we find that citrulline is exported from macrophages during early stages of NO production with <2% retained for recycling via the Ass1-Asl pathway. Later, extracellular arginine is depleted, and Ass1 expression allows macrophages to synthesize arginine from imported citrulline to sustain NO output. Ass1-deficient macrophages fail to salvage citrulline in arginine-scarce conditions, leading to their inability to control mycobacteria infection. Thus, extracellular arginine fuels rapid NO production in activated macrophages, and citrulline recycling via Ass1 and Asl is a fail-safe system that sustains optimum NO production.

Nitric oxide effect on root architecture development in Malus seedlings

&amp;nbsp;The time-dependent production of nitric oxide (NO) in roots induced by indole-3-butyric acid (IBA) and the effect of sodium nitroprusside (SNP) on root architecture development were investigated, using Malus hupehensis Rehd. seedlings. Following IBA application, a very rapid increase in NO formation and a subsequent second wave of NO burst was observed, which was related to the induction of lateral roots (LRs) and the organogenesis of lateral root primordia (LRP), respectively. The first NO burst was correlated with the second and the two peaks of NO burst induced by IBA were totally abolished by 3,3&amp;rsquo;,4&amp;rsquo;,5,7-pentahydroxyflavone (quercetin). Exogenous NO promoted the emergence and elongation of LR and inhibited the elongation of primary root (PR) in a dose-dependent manner: low concentrations of SNP promoted both the amounts and the elongation of LR but inhibited the elongation of LR and PR at higher concentrations. It was concluded that (i) the rapid production of NO induced by IBA was correlated with the IBA-induced initiation of LR; (ii) quercetin inhibition of IBA-induced LR formation was correlated with the quercetin inhibition of IBA-induced NO biosynthesis, and (iii) exogenous NO affects the development of root system architecture in a dose-dependent manner.

NO way to treat a cold

Gupta, K. J., Hinch, D. K., Mur, L. A. (2011). NO way to treat a cold. New Phytologist, 189, (2), 360-363. IMPF: 06.64

Phosphatidic acid production in chitosan-elicited tomato cells, via both phospholipase D and phospholipase C/diacylglycerol kinase, requires nitric oxide

Nitric oxide (NO) and the lipid second messenger phosphatidic acid (PA) are involved in plant defense responses during plant–pathogen interactions. NO has been shown to be involved in the induction of PA production in response to the pathogen associated molecular pattern (PAMP) xylanase in tomato cells. It was shown that NO is critical for PA production induced via phospholipase C (PLC) in concerted action with diacylglycerol kinase (DGK) but not for the xylanase-induced PA via phospholipase D (PLD). In order to study whether this is a general phenomenon during PAMP perception or if it is particular for xylanase, we studied the effect of the PAMP chitosan in tomato cell suspensions. We observed a rapid NO production in tomato cells treated with chitosan. Chitosan induced the formation of PA by activating both PLD and PLC/DGK. The activation of either phospholipase-mediated signaling pathway was inhibited in cells treated with the NO scavenger cPTIO. This indicates that NO is required for PA generation via both the PLD and PLC/DGK pathway during plant defense response in chitosan elicited cells. Responses downstream PA were studied. PLC inhibitors neomycin and U73122 inhibited chitosan-induced ROS production. Differences between xylanase and chitosan-induced phospholipid signaling pathways are discussed.

Molecular mechanisms of generation for nitric oxide and reactive oxygen species, and role of the radical burst in plant immunity.

Rapid production of nitric oxide (NO) and reactive oxygen species (ROS) has been implicated in the regulation of innate immunity in plants. A potato calcium-dependent protein kinase (StCDPK5) activates an NADPH oxidase StRBOHA to D by direct phosphorylation of N-terminal regions, and heterologous expression of StCDPK5 and StRBOHs in Nicotiana benthamiana results in oxidative burst. The transgenic potato plants that carry a constitutively active StCDPK5 driven by a pathogen-inducible promoter of the potato showed high resistance to late blight pathogen Phytophthora infestans accompanied by HR-like cell death and H(2)O(2) accumulation in the attacked cells. In contrast, these plants showed high susceptibility to early blight necrotrophic pathogen Alternaria solani, suggesting that oxidative burst confers high resistance to biotrophic pathogen, but high susceptibility to necrotrophic pathogen. NO and ROS synergistically function in defense responses. Two MAPK cascades, MEK2-SIPK and cytokinesis-related MEK1-NTF6, are involved in the induction of NbRBOHB gene in N. benthamiana. On the other hand, NO burst is regulated by the MEK2-SIPK cascade. Conditional activation of SIPK in potato plants induces oxidative and NO bursts, and confers resistance to both biotrophic and necrotrophic pathogens, indicating the plants may have obtained during evolution the signaling pathway which regulates both NO and ROS production to adapt to wide-spectrum pathogens.

Nitric Oxide Potentiates Oligosaccharide‐induced Artemisinin Production in Artemisia annua Hairy Roots

The purpose of the present study was to characterize the generation of nitric oxide (NO) in Artemisia annua roots induced by an oligosaccharide elicitor (OE) from Fusarium oxysporum mycelium and the potentiation role of NO in the elicitation of artemisinin accumulation. The OE (0.3 mg total sugar/mL) induced a rapid production of NO in cultures, which exhibited a biphasic time course, reaching the first plateau within 1.5 h and the second within 8 h of OE treatment. Artemisinin content in 20-day-old hairy roots was increased from 0.7 mg/g dry wt to 1.3 mg/g dry wt by using the OE treatment for 4 d. In the absence of OE, the NO donor sodium nitroprusside (SNP) at 10, 50 microM and 100 microM enhanced the growth of hairy roots, but had no effect on artemisinin synthesis. The combination of SNP with OE increased artemisinin content from 1.2 mg/g dry wt to 2.2 mg/g dry wt, whereas the maximum production of artemisinin in cultures was 28.5 mg/L, a twofold increase over the OE treatment alone. The effects of SNP on the OE-induced artemisinin were suppressed strongly by the NO scavenger 2-(4-carboxyphenyl)-4,4,5,5-tetramethylimidazoline-1-oxyl-3-oxide (cPTIO). The results suggest that NO can strongly potentiate elicitor-induced artemisinin synthesis in A. annua hairy roots.

Signaling pathway of ginsenoside-Rg1 leading to nitric oxide production in endothelial cells

We here provide definitive evidence that ginsenoside-Rg1, the pharmacologically active component of ginseng, is a functional ligand of the glucocorticoid receptor (GR) as determined by fluorescence polarization assay. Rg1 increased the phosphorylation of GR, phosphatidylinositol-3 kinase (PI3K), Akt/PKB and endothelial nitric oxide synthase (eNOS) leading to increase nitric oxide (NO) production in human umbilical vein endothelial cell. Rg1-induced eNOS phosphorylation and NO production were significantly reduced by RU486, LY294,002, or SH-6. Also, knockdown of GR completely eliminated the Rg1-induced NO production. This study revealed that Rg1 can indeed serve as an agonist ligand for GR and the activated GR can induce rapid NO production from eNOS via the non-transcriptional PI3K/Akt pathway.

Estrogen‐mediated nitric oxide (NO) production in cultured human vascular endothelial cells

Estrogen (E2) is reported to induce the rapid activation of endothelial nitric oxide synthase (eNOS) and NO release, resulting in vasodilation, decreased platelet adhesion and angiogenesis in the vessel wall. In this study, we have used a cell line (EA.hy926) derived from human umbilical vein endothelial cells (HUVECs) to investigate the cellular mechanism underlying E2-induced NO synthesis. Experimentally, NO production and cytosolic free [Ca2+] were monitored using the NO-sensitive dye DAF-FM and Fluo-3, respectively, and agonist-induced changes in membrane potential were recorded using patch clamp techniques. E2 dose-dependently induced rapid increases in NO synthesis, and only modest changes in cytosolic [Ca2+]. The PI3 kinase inhibitor LY294002, the E2 receptor antagonist ICI 182,780, and the eNOS inhibitor L-NAME all blocked E2-mediated NO synthesis. Interestingly, removal of extracellular Ca2+, buffering of cytosolic Ca2+ by BAPTA or inhibition of SK and IK Ca-activated K+ channels by apamin and charybdotoxin did not affect NO production in response to E2, but attenuated ATP-mediated NO synthesis. Unlike ATP or histamine, E2 did not induce hyperpolarization of endothelial cell membrane potential. These observations indicate that in human vascular endothelial cells, E2 induces rapid NO production via a cellular pathway distinct from that utilized by Ca-mobilizing stimuli. (Funded by CIHR)

Nitric Oxide is Involved in Methyl Jasmonate-induced Defense Responses and Secondary Metabolism Activities of Taxus Cells

Methyl jasmonate (MeJA), a methyl ester of jasmonic acid (JA), is a well-established signal molecule in plant defense responses and an effective inducer of secondary metabolite accumulation in plant cell cultures such as the valuable anticancer diterpenoid taxol (paclitaxel) in Taxus spp. This work examines the involvement of nitric oxide (NO) in MeJA-induced plant defense responses and secondary metabolism in Taxus chinensis cell cultures. Exogenously supplied MeJA at 100 microM induced rapid production of NO in the Taxus cell cultures, reaching a maximum within 6 h of MeJA supply. Several other responses occurred concomitantly, including the production of hydrogen peroxide (H2O2), and the increases in intracellular malondialdehyde (MDA) content, lipoxygenase (LOX) and phenylalanine ammonium-lyase (PAL) activities. The MeJA-induced H2O2 production was suppressed by an NO donor, sodium nitroprusside (SNP), but enhanced by NO inhibitors, N (omega)-nitro-L-arginine (L-NNA) and 2-phenyl-4,4,5,5-tetramethyl-imidazoline-1-oxyl-3-oxide (PTIO). In contrast, the MeJA-induced MDA, LOX and PAL were all enhanced by the NO donor but suppressed by the NO inhibitors. The NO inhibitors also suppressed MeJA-induced taxol accumulation. These results are suggestive of a role for NO as a signal element for activating the MeJA-induced defense responses and secondary metabolism activities of plant cells.

Hydrogen Peroxide Induces a Rapid Production of Nitric Oxide in Mung Bean (Phaseolus aureus)

Nitric oxide (NO) has recently been identified as an important signaling molecule in plant immune response. The present study aims to investigate the signaling pathway that leads to NO production. Using the NO specific fluorescent dye DAF-2DA, we observed rapid production of NO in mung bean leaves after the addition of 10 mM hydrogen peroxide (H2O2). NO was probably produced by a NOS-like enzyme in plants, as the NO production was inhibited by l-NAME, a NOS inhibitor. The NOS-like activity in the total leaf protein preparation of mung bean (Phaseolus aureus) was elevated 8.3-fold after 10 mM H2O2 treatment, as demonstrated using the chemiluminescence NOS assay. The NOS-like activity was BH4 dependent: omitting BH4 in the reaction mixture of NOS assay reduced the NOS activity by 76%. We also found that the H2O2 induced NO production was mediated via calcium ion flux, as it was blocked in the presence of a calcium ion channel blocker, verapamil. Results from the present study identified H2O2 as an upstream signal that leads to NO production in plants. H2O2 and NO, besides acting as two independent signaling molecules in plant immune response, may interrelate to form an oxidative cell death (OCD) cycle.

Nitric oxide is produced by Cowdria ruminantium-infected bovine pulmonary endothelial cells in vitro and is stimulated by gamma interferon.

Nitric oxide (NO) is a labile inorganic free radical produced by NO synthase from the substrate L-arginine in various cells and tissues including endothelial cells. A substantial elevation of nitrite levels indicative of NO production occurred in cultures of Cowdria ruminantium-infected bovine pulmonary endothelial cells (BPEC) incubated in medium alone. Exposure of the infected cultures to recombinant bovine gamma interferon (BorIFN-gamma) resulted in more rapid production of NO, reduced viability of C. ruminantium, and induction of endothelial cell death. Significant inhibition of NO production was noted after addition of the NO synthase inhibitor N-monomethyl-L-arginine (L-NMMA), indicating that the increase in production occurred via the inducible NO synthase pathway. Reduction in the infectivity of C. ruminantium elementary bodies (EBs) occurred in a dose-dependent manner after incubation with the NO donor molecule S-nitroso-N-acetyl-DL-penicillamine (SNAP) prior to infection of endothelial cells. The level of infection in cultures maintained in SNAP was reduced in a dose-dependent manner with significant negative correlation between the final level of infection on day 7 and the level of SNAP (r = -0.96). It was established that pretreatment and cultivation of C. ruminantium EBs with the NO donor molecule SNAP reduced infectivity to cultures and viability of EBs with the implication that release of NO in vivo following infection of endothelial cells may have an effect upon the multiplication of the agent in the host animal and may be involved in the pathogenesis of heartwater through the effect of this molecule upon circulation.